The drugs join more than 250 no-cost prescriptions on Walmart's medical plans next year, subject to prior approval.
Recap by typeshit. Full story at Yahoo Finance.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
Novo Nordisk is cutting what Wegovy costs in China, Polskie Radio reports. Tap through for the size of the cut and when it takes effect.
The drug behind Mounjaro and Zepbound slowed tumors in an early mouse study. Obesity is tied to higher breast cancer risk, especially after menopause, so the work is drawing interest.
The drug behind Mounjaro and Zepbound held back tumor growth in mouse studies. It's early animal work, but obesity is tied to higher breast cancer risk.
Loading…